Skip to main content
VIKAS LIFECARE LIMITED logo

VIKAS LIFECARE LIMITED — Investor Relations & Filings

Ticker · VIKASLIFE ISIN · INE161L01027 LEI · 9845008856U9D9DABE98 BSE.NS Manufacturing
Open in API
Filings indexed 504 across all filing types
Latest filing 2024-04-05 Capital/Financing Update
Country IN India
Listing BSE.NS VIKASLIFE

About VIKAS LIFECARE LIMITED

https://www.vikaslifecarelimited.com

Vikas Lifecare Limited is a diversified enterprise specializing in the manufacturing and trading of polymer and rubber compounds, specialty additives, and chemicals. The company produces high-performance polymer compounds utilized in sectors such as footwear, automotive, and infrastructure. Beyond its core chemical business, it has expanded into the Fast-Moving Consumer Goods (FMCG) and agro-products markets, focusing on the processing and distribution of premium food products. The company also provides infrastructure solutions, specifically in the domain of smart gas metering. A key aspect of its operations is the integration of recycled materials into its production cycles, reflecting a commitment to sustainable manufacturing. Its strategic focus involves vertical integration and portfolio diversification to address evolving industrial and consumer demands.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Capital/Financing Update Classification · 95% confidence The document is a formal communication from Vikas Lifecare Limited to the stock exchanges (NSE and BSE) regarding the outcome of a Board Meeting held on April 5, 2024. The main content details the conversion of 5,20,00,000 warrants into an equal number of equity shares, including specifics about the issue price, allotment, and the resulting increase in paid-up capital. It references compliance with SEBI regulations and provides detailed disclosures as per SEBI Listing Regulations. The document is an announcement of a corporate action related to capital structure changes, specifically the allotment of shares upon conversion of warrants. It is not a full financial report, audit report, or earnings release, nor is it a transcript or management discussion. It is also not a proxy statement or voting result. The document is primarily an update on a capital/financing event (conversion of warrants to equity shares). Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (6803 characters) and detailed content support this classification with high confidence.
2024-04-05 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Listing Compliance Departments of NSE and BSE, disclosing receipt of an administrative warning letter from SEBI regarding noncompliance with listing regulations. It states that the company has made a delayed disclosure and that there is no impact on financial or operational activities. The document is a regulatory announcement about compliance and does not contain financial statements, audit information, or detailed report content. It is short (2693 characters) and serves as a regulatory disclosure under SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-04-03 English
Updates
Regulatory Filings Classification · 95% confidence The document is an official communication from Vikas Lifecare Limited addressed to the stock exchanges (NSE and BSE) under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about a judicial order passed by the Hon’ble Additional District Judge, Alwar, Rajasthan, in a legal dispute involving shareholding and capital structure issues related to another company, M/s Cupid Limited. The document details the court's directions, the parties involved, and the implications of the order. It does not contain financial statements, earnings data, or detailed management analysis. Instead, it is a regulatory disclosure about a legal proceeding and court order affecting the company or its interests. The document is not a full legal proceeding report but a regulatory announcement of a significant legal event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-04-02 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about the closure of the trading window in compliance with SEBI regulations related to insider trading. It mentions the upcoming declaration of audited financial results but does not contain any financial data or results itself. The document is short (2037 characters) and serves as an announcement regarding trading restrictions ahead of financial results disclosure. Therefore, it is not a financial report or earnings release but a regulatory announcement related to compliance and trading restrictions. This fits best under Regulatory Filings (RNS).
2024-03-29 English
Updates
Capital/Financing Update Classification · 95% confidence The document is a media release announcing that Vikas Lifecare Limited has acquired a 7.5% equity stake in Benchmark News Lab Private Limited by investing INR 150 million. It is addressed to the stock exchanges (NSE and BSE) pursuant to SEBI regulations, indicating a regulatory disclosure. The content focuses on the acquisition and business expansion plans, with no financial statements, detailed financial analysis, or quarterly/annual results presented. The document is a formal announcement of a capital investment and stake acquisition, which fits the category of Capital/Financing Update (CAP). The document length is 7762 characters, which is sufficient for a detailed announcement but does not contain financial reports or earnings data. Therefore, the appropriate classification is CAP with high confidence.
2024-03-28 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (NSE and BSE) regarding additional details required for a corporate announcement previously filed about the resignation of the Chief Executive Officer. It references compliance with SEBI regulations and includes resignation letters as attachments. The document is short (1859 characters) and serves as a regulatory update or compliance communication rather than a full report or detailed announcement. It does not contain financial data, management discussion, or detailed corporate governance information but is related to a management change. However, since it is primarily a regulatory compliance communication and not a formal announcement of board or management changes itself, it fits best under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory communications that do not fit other categories.
2024-03-26 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.